Dr Reddys Laboratories announces acquisition of partial ownership interest in AWACS and Trikaal

Last Updated : Apr 01 2021 | 12:04 PM IST

Dr Reddys Laboratories announced that the company's investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has, through its wholly-owned entity DigiHealth Technologies LLP, acquired 66.02% ownership interest in AIOCD Pharmasofttech Awacs Private (AWACS) though a combination of (i) direct purchase of 50% ownership interest in AWACS and (ii) indirect purchase of 16.02% ownership interest in AWACS through acquisition of 32.04% shareholding interest in Trikaal Mediinfotech. It is also agreed to acquire the balance stake subject to fulfilment of certain terms and conditions.

The cost of acquisition for the combined transaction of AWACS and Trikaal is approximately Rs 75 crores for acquisition of 100% stake in AWACS and Trikaal (direct and indirect together).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Already subscribed? Log in

Subscribe to read the full story →

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

In-depth market analysis & insights with access to The Smart Investor

Ad-free Reading

Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

Access Business Standard across devices — mobile, tablet, or PC, via web or app

SAVE 25%

Subscribe for ₹2,700 / 1 Year

Connect with us on WhatsApp

Dr Reddys Laboratories announces acquisition of partial ownership interest in AWACS and Trikaal